drugset / Trial / NCT01331655

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

NCT01331655

Phase 3 Withdrawn Bayer
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this three-arm study is to evaluate the effect of a flexible extended regimen of an EE+DRSP containing OC on bleeding pattern and to investigate the compliance with daily pill intake when the investigational product is provided in a blister package or a compliance aiding dispenser with a pill reminder function. The third treatment arm will be a reference comparator arm of a standard 24+4 regimen of the identical hormone combination.

Timeline

Start
2013-04
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject 5-MTHF Unknown 0.451 mg Oral
Subject EE Unknown 0.02 mg Oral
Subject drospirenone Unknown 3 mg Oral

Indications

No indication recorded.